CRYCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。CRY遺伝子サイレンサーは、CRY CRISPR/Cas9ノックアウトプラスミドとCRYDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のCRYCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
CRY CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
CRY1 CRISPR/Cas9 KOプラスミド (h) | sc-400946 | h | Gene Knockout | GFP | 0 | ||
CRY1 HDRプラスミド (h) | sc-400946-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CRY1 Double Nickaseプラスミド (h) | sc-400946-NIC | h | Gene Knockout | Puromycin | 0 | ||
CRY1 Double Nickaseプラスミド (h2) | sc-400946-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CRY1 CRISPR/Cas9 KOプラスミド (m2) | sc-419818-KO-2 | m | Gene Knockout | GFP | 0 | ||
CRY1 HDRプラスミド (m2) | sc-419818-HDR-2 | m | Homology Directed Repair | Puromycin | 0 | ||
CRY1 Double Nickaseプラスミド (m) | sc-419818-NIC | m | Gene Knockout | Puromycin | 0 | ||
CRY1 Double Nickaseプラスミド (m2) | sc-419818-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
CRY2 CRISPR/Cas9 KOプラスミド (h) | sc-403171 | h | Gene Knockout | GFP | 0 | ||
CRY2 HDRプラスミド (h) | sc-403171-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CRY2 Double Nickaseプラスミド (h) | sc-403171-NIC | h | Gene Knockout | Puromycin | 0 | ||
CRY2 Double Nickaseプラスミド (h2) | sc-403171-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CRY2 CRISPR/Cas9 KOプラスミド (m2) | sc-419819-KO-2 | m | Gene Knockout | GFP | 0 | ||
CRY2 HDRプラスミド (m2) | sc-419819-HDR-2 | m | Homology Directed Repair | Puromycin | 0 | ||
CRY2 Double Nickaseプラスミド (m) | sc-419819-NIC | m | Gene Knockout | Puromycin | 0 | ||
CRY2 Double Nickaseプラスミド (m2) | sc-419819-NIC-2 | m | Gene Knockout | Puromycin | 0 |
CRY CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
CRY1 CRISPR Activationプラスミド (h) | sc-400946-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY1 CRISPR Activationプラスミド (h2) | sc-400946-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY1 Lentiviral Activation Particles (h) | sc-400946-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY1 Lentiviral Activation Particles (h2) | sc-400946-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY1 CRISPR Activationプラスミド (m) | sc-419818-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY1 CRISPR Activationプラスミド (m2) | sc-419818-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY1 Lentiviral Activation Particles (m) | sc-419818-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY1 Lentiviral Activation Particles (m2) | sc-419818-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY2 CRISPR Activationプラスミド (h) | sc-403171-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY2 CRISPR Activationプラスミド (h2) | sc-403171-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY2 Lentiviral Activation Particles (h) | sc-403171-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY2 Lentiviral Activation Particles (h2) | sc-403171-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY2 CRISPR Activationプラスミド (m) | sc-419819-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY2 CRISPR Activationプラスミド (m2) | sc-419819-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY2 Lentiviral Activation Particles (m) | sc-419819-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRY2 Lentiviral Activation Particles (m2) | sc-419819-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |